Quick Answer
Zomedica Corp. reported Operating Income of -$84.35 million for fiscal year 2025.
Zomedica Corp. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$84.35M | -65.2% |
| 2024 | -$51.05M | -18.0% |
| 2023 | -$43.27M | -97.4% |
| 2022 | -$21.92M | -2.6% |
| 2021 | -$21.37M | -27.5% |
| 2020 | -$16.76M | +15.3% |
| 2019 | -$19.78M | -19.3% |
| 2018 | -$16.58M | -105.1% |
| 2017 | -$8.08M | -41.2% |
| 2016 | -$5.73M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.61M | +11.2% | +17.8% |
| June 30, 2025 | -$8.04M | +67.9% | +87.6% |
| March 31, 2025 | -$64.55M | -521.5% | -767.6% |
| September 30, 2024 | -$7.44M | -25.1% | +70.3% |
| June 30, 2024 | -$25.07M | -271.8% | -141.4% |
| March 31, 2024 | -$10.39M | -38.3% | -74.6% |
| September 30, 2023 | -$5.95M | +9.8% | +11.8% |
| June 30, 2023 | -$6.74M | -14.7% | +10.3% |
- Zomedica Corp. showed a decrease of -65.2% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Zomedica Corp.’s operating income has declined by 1373.1% (from -$5.73 million to -$84.35 million).
- The most recent figure is from Zomedica Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: